Meningococcal infections. 2. Field trial of group C meningococcal polysaccharide vaccine in 1969-70

Bull World Health Organ. 1971;45(3):279-82.

Abstract

A second large-scale field trial of group C meningococcal polysaccharide vaccine in US Army recruits confirmed the efficacy and safety of the vaccine. When the results of all studies over a 2-year period were combined, the reduction in group-specific disease rates was 89.5%.

MeSH terms

  • Bacterial Vaccines*
  • Humans
  • Male
  • Meningococcal Infections / prevention & control*
  • Military Medicine*
  • Polysaccharides, Bacterial / administration & dosage*
  • United States
  • Vaccination

Substances

  • Bacterial Vaccines
  • Polysaccharides, Bacterial